BioAge Labs (BIOA) Total Current Liabilities (2023 - 2026)

BioAge Labs has disclosed Total Current Liabilities across 4 years of filings, most recently posting $19.2 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 15.85% year-over-year to $19.2 million; the TTM figure through Jun 2026 stood at $19.2 million (down 15.85% YoY), while the FY2025 annual figure was $20.1 million, down 27.5% from the prior year.
• Total Current Liabilities came in at $19.2 million for Q2 2026 at BioAge Labs, up from $15.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $58.2 million in Q4 2023 to a low of $15.8 million in Q1 2026.
• Average Total Current Liabilities over 4 years is $25.7 million, with a median of $22.8 million recorded in 2025.
• Year-over-year, Total Current Liabilities plunged 52.25% in 2024 and rose 28.37% in 2025.
• Over 4 years, Total Current Liabilities stood at $58.2 million in 2023, then sank by 52.25% to $27.8 million in 2024, then decreased by 27.5% to $20.1 million in 2025, then fell by 4.57% to $19.2 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $19.2 million in Q2 2026, $15.8 million in Q1 2026, and $20.1 million in Q4 2025.